Amoxicillin-OVA
Amoxicillin-OVA is a conjugate of Amoxicillin and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].
Product Specifications
UNSPSC
12352100
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
[Amoxicillin-OVA]
References & Citations
[1]Guo Y, et, al. Metabolic response of Lactobacillus acidophilus exposed to amoxicillin. J Antibiot (Tokyo) . 2022 May;75 (5) :268-281.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PT_72729-01 2 µg
Phosphoethanolamine / Phosphocholine Phosphatase Human Recombinant
Sign In for Pricing
View Details PT_72729-02 10 µg
Phosphoethanolamine / Phosphocholine Phosphatase Human Recombinant
Sign In for Pricing
View Details PT_72729-03 1 mg
Phosphoethanolamine / Phosphocholine Phosphatase Human Recombinant
Sign In for Pricing
View Details 
MBS1104317-01 0.02 mg (E-Coli)
Recombinant Bacillus amyloliquefaciens Putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase (RBAM_016840)
Sign In for Pricing
View Details MBS1104317-02 0.02 mg (Yeast)
Recombinant Bacillus amyloliquefaciens Putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase (RBAM_016840)
Sign In for Pricing
View Details MBS1104317-03 0.1 mg (E-Coli)
Recombinant Bacillus amyloliquefaciens Putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase (RBAM_016840)
Sign In for Pricing
View Details